{"DataElement":{"publicId":"2960410","version":"1","preferredName":"Vaccine Endotoxin Measurement Value","preferredDefinition":"Numeric value to represent the endotoxin content in a vaccine formulation.","longName":"VACC_EDTX_MSRMT_VAL","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2960384","version":"1","preferredName":"Vaccine Endotoxin Measurement","preferredDefinition":"Suspensions of killed or attentuated microorganisms (bacteria, viruses, or rickettsiae), or of antigenic proteins derived from them, administered for the prevention, amelioration, or treatment of infectious diseases or cancer._The lipopolysaccharide complexes that are part of the outer membrane of the cell wall of Gram-negative bacteria such as E. coli, Salmonella, Shigella, Pseudomonas, Neisseria, Haemophilus, and other leading pathogens. Upon bacterial infections, the lipid component (Lipid A) of endotoxin contributes to its toxicity, while the polysaccharide components contribute to immunogenicity._Measurement is the determination of the size or magnitude of something.  It is also used ro refer to the result of this act.","longName":"2960382v1.0:2697685v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2960382","version":"1","preferredName":"Vaccine Endotoxin","preferredDefinition":"Suspensions of killed or attentuated microorganisms (bacteria, viruses, or rickettsiae), or of antigenic proteins derived from them, administered for the prevention, amelioration, or treatment of infectious diseases or cancer.:The lipopolysaccharide complexes that are part of the outer membrane of the cell wall of Gram-negative bacteria such as E. coli, Salmonella, Shigella, Pseudomonas, Neisseria, Haemophilus, and other leading pathogens. Upon bacterial infections, the lipid component (Lipid A) of endotoxin contributes to its toxicity, while the polysaccharide components contribute to immunogenicity.","longName":"C923:C50918","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vaccine","conceptCode":"C923","definition":"Preparations containing substances with antigenic properties administered to activate the immune system, thereby inducing an immune response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Endotoxin","conceptCode":"C50918","definition":"The lipopolysaccharide complexes that are part of the outer membrane of the cell wall of Gram-negative bacteria such as E. coli, Salmonella, Shigella, Pseudomonas, Neisseria, Haemophilus, and other leading pathogens. Upon bacterial infections, the lipid component (Lipid A) of endotoxin contributes to its toxicity, while the polysaccharide components contribute to immunogenicity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"780B7F9B-CDE1-2E47-E040-BB89AD431007","latestVersionIndicator":"Yes","beginDate":"2009-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-10","modifiedBy":"ONEDATA","dateModified":"2009-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2697685","version":"1","preferredName":"Measurement - Retired","preferredDefinition":"Measurement is the determination of the size or magnitude of something.  It is also used ro refer to the result of this act.","longName":"C37990","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurement","conceptCode":"C37990","definition":"Measurement is the determination of the size or magnitude of something.  It is also used ro refer to the result of this act.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F3A26C9-F4EB-2F59-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-11-18","modifiedBy":"DWARZEL","dateModified":"2023-03-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"780B7F9B-CDEF-2E47-E040-BB89AD431007","latestVersionIndicator":"Yes","beginDate":"2009-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-10","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2960389","version":"1","preferredName":"Vaccine Endotoxin Value","preferredDefinition":"Suspensions of killed or attentuated microorganisms (bacteria, viruses, or rickettsiae), or of antigenic proteins derived from them, administered for the prevention, amelioration, or treatment of infectious diseases or cancer._The lipopolysaccharide complexes that are part of the outer membrane of the cell wall of Gram-negative bacteria such as E. coli, Salmonella, Shigella, Pseudomonas, Neisseria, Haemophilus, and other leading pathogens. Upon bacterial infections, the lipid component (Lipid A) of endotoxin contributes to its toxicity, while the polysaccharide components contribute to immunogenicity._A numerical quantity measured or assigned or computed.","longName":"VACC_EDTX_VAL","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"EU/Kg ","minLength":null,"maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":"3","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2960388","version":"1","preferredName":"Vaccine Endotoxin Value","preferredDefinition":"Suspensions of killed or attentuated microorganisms (bacteria, viruses, or rickettsiae), or of antigenic proteins derived from them, administered for the prevention, amelioration, or treatment of infectious diseases or cancer.:The lipopolysaccharide complexes that are part of the outer membrane of the cell wall of Gram-negative bacteria such as E. coli, Salmonella, Shigella, Pseudomonas, Neisseria, Haemophilus, and other leading pathogens. Upon bacterial infections, the lipid component (Lipid A) of endotoxin contributes to its toxicity, while the polysaccharide components contribute to immunogenicity.:A numerical quantity measured or assigned or computed.","longName":"C923:C50918:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vaccine","conceptCode":"C923","definition":"Preparations containing substances with antigenic properties administered to activate the immune system, thereby inducing an immune response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Endotoxin","conceptCode":"C50918","definition":"The lipopolysaccharide complexes that are part of the outer membrane of the cell wall of Gram-negative bacteria such as E. coli, Salmonella, Shigella, Pseudomonas, Neisseria, Haemophilus, and other leading pathogens. Upon bacterial infections, the lipid component (Lipid A) of endotoxin contributes to its toxicity, while the polysaccharide components contribute to immunogenicity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"780B7F9B-CE71-2E47-E040-BB89AD431007","latestVersionIndicator":"Yes","beginDate":"2009-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-10","modifiedBy":"ONEDATA","dateModified":"2009-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"780B7F9B-CE82-2E47-E040-BB89AD431007","latestVersionIndicator":"Yes","beginDate":"2009-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-10","modifiedBy":"REEVESD","dateModified":"2009-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2811715","version":"1","longName":"Duke University","context":"NCIP"},{"publicId":"2812724","version":"1","longName":"Duke U New CDEs","context":"NCIP"}]},{"publicId":"3886752","version":"1","longName":"For Review","context":"DCI","ClassificationSchemeItems":[{"publicId":"3891931","version":"1","longName":"For Review","context":"DCI"}]}],"AlternateNames":[{"name":"DCI","type":"USED_BY","context":"DCI"}],"ReferenceDocuments":[{"name":"Endotoxin","type":"Preferred Question Text","description":"Endotoxin","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"781490A4-50BC-A25E-E040-BB89AD432624","latestVersionIndicator":"Yes","beginDate":"2009-11-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-11","modifiedBy":"ZHANGWE","dateModified":"2013-09-16","changeDescription":"Curated to support Duke University adoption of C3D","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}